Dipeptidyl peptidase-4 inhibitors and the risks of autoimmune diseases in type 2 diabetes mellitus patients in Taiwan: a nationwide population-based cohort study

AIMS: Dipeptidyl peptidase-4, a transmembrane glycoprotein expressed in various cell types, serves as a co-stimulator molecule to influence immune response. This study aimed to investigate associations between DPP-4 inhibitors and risk of autoimmune disorders in patients with type 2 diabetes mellitu...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Acta Diabetol
Главные авторы: Chen, Yi-Chuan, Chen, Tien-Hsing, Sun, Chi-Chin, Chen, Jau-Yuan, Chang, Shy-Shin, Yeung, Ling, Tsai, Yi-Wen
Формат: Artigo
Язык:Inglês
Опубликовано: Springer Milan 2020
Предметы:
Original Article
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC7173685/
https://ncbi.nlm.nih.gov/pubmed/32318876
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00592-020-01533-5
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы